The mechanism by which the cholesterol pre- Extensive evidence indicates that the synthesis of cholesterol and particularly of mevalonic acid, the rate-limiting intermediate of cholesterogenesis, is closely linked to normal cell growth (1-6). Previous studies from this and other laboratories have, moreover, demonstrated that the uncontrolled synthesis of mevalonic acid is a unique and characteristic feature of all malignant (7) (8) (9) (10) (11) (12) (13) (14) and premalignant (7) tumors in vivo. The process by which mevalonate production may be linked to both normal and pathological cell replication has been suggested by the recent discovery that the synthesis of mevalonate, independent of its function as a cholesterol precursor, plays an essential role in the S phase of DNA synthesis (15, 16). To investigate the mechanism by which mevalonate regulates DNA replication, we examined the interaction between various mevalonate derivatives and several known inhibitors of DNA synthesis.
pactin suppresses DNA synthesis specifically during the S phase of the cell cycle. In the present study, known mevalonate derivatives were examined as possible mediators by which mevalonate controls DNA replication. Of the compounds studied, only isopentenyladenine and its 4'-hydroxylated analogue, zeatin, could substitute for mevalonate in restoring DNA replication in compactin-blocked cells. Moreover, these two derivatives proved to be at least 100 times more active than mevalonate, and both restored DNA replication to normal within 15 min of their being added to the medium. In addition, isopentenyladenine, like mevalonate, stimulated DNA synthesis specifically during the S phase of the cell cycle. Isopentenyladenine also reversed the inhibition of DNA synthesis caused by nalidixic acid, an antibiotic that does not inhibit cholesterol synthesis. These findings indicate that isopentenyladenine or a closely related derivative may mediate the regulatory role of mevalonate in DNA replication and suggest that such isoprenes may act upon DNA replication at a site common to that inhibited by nalidixic acid.
Extensive evidence indicates that the synthesis of cholesterol and particularly of mevalonic acid, the rate-limiting intermediate of cholesterogenesis, is closely linked to normal cell growth (1) (2) (3) (4) (5) (6) . Previous studies from this and other laboratories have, moreover, demonstrated that the uncontrolled synthesis of mevalonic acid is a unique and characteristic feature of all malignant (7) (8) (9) (10) (11) (12) (13) (14) and premalignant (7) tumors in vivo. The process by which mevalonate production may be linked to both normal and pathological cell replication has been suggested by the recent discovery that the synthesis of mevalonate, independent of its function as a cholesterol precursor, plays an essential role in the S phase of DNA synthesis (15, 16) . To investigate the mechanism by which mevalonate regulates DNA replication, we examined the interaction between various mevalonate derivatives and several known inhibitors of DNA synthesis.
The major finding of the present study is that isopentenyladenine, a known isoprene product of mevalonic acid in bacteria, and 4'-hydroxylisopentenyladenine (zeatin) are at least 100 times more active than mevalonic acid in rapidly restoring DNA replication to cells in which mevalonate production is blocked with the competitive enzyme inhibitor, compactin. This finding suggests that isopentenyladenine or a closely related compound may represent the mediator through which mevalonate controls S-phase DNA replications.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 neomycin solution (100,000 Mg/ml), and penicillin (10,000 units/ml). All culture media supplements were obtained from GIBCO. Fetal calf serum (340 ,ug of cholesterol per ml) was added to the culture media at a final concentration of 12% (vol/vol).
Compactin. The inhibitor, ML-236B (compactin), a gift of R. Fears (Beecham Pharmaceuticals, Epsom, England) and of Akira Endo (Sankyo, Tokyo) was brought into solution as described (17) .
Cell Culture. BHK-21 cells (a nonmalignant, transformed fibroblast cell line) were obtained from the Cell Culture Facility of the University of California, San Francisco. Stock cells were subcultured by exposing them for 1 min to a 0.25% trypsin solution. Fresh medium was then added to the detached cells and the cells were subcultured at a split ratio of 1:4. All experiments were carried out in 60 X 15 mm petri dishes at a cell concentration of approximately 4 (2 , uCi /ml) at 370C in 3 ml of phosphate-buffered saline. After incubation, the medium from each petri dish was transferred into a 50-ml screwtop glass tube; the cells then were dissolved in 1 ml of 0.1 M NaOH and added to the medium from the corresponding petri dish. To each 4 ml of this mixture, 7 ml of 70% ethanol/45% KOH/H20, 5:1:2 (vol/vol), and 105 cpm of [1,2-3H]cholesterol, as an internal standard, were added. Each sample then was saponified and extracted with petroleum ether three times. The petroleum ether phase was evaporated to dryness, and the total 3-hydroxysterols were isolated as described by Langdon and Bloch (19) .
Protein Determination. Protein concentrations were measured by the method of Lowry et al. (20) with bovine serum albumin as the standard. RESULTS Effect of Mevalonate Derivatives on Compactin-Inhibited DNA Replication. The initial aim of this study was to determine whether a derivative of mevalonate might mediate the previously demonstrated role of this sterol precursor in regulating DNA replication. Accordingly, a number of known mevalonate products were examined for their ability to reverse the compactin-induced inhibition of DNA replication in synchronized BHK cells. As shown in Fig. 1 , only isopentenyladenine (Fig. 2 Left) and its 4'-hydroxyl analogue zeatin ( Fig.  2 Right) could reproduce the effect of mevalonic acid in restoring DNA replication in compactin-blocked cells. Moreover, at the concentrations used, both isopentenyladenine and zeatin increased DNA synthesis in levels greater than that in the control cells. Other isoprenes (isopentenyladenosine, dolichol, and coenzyme Q) as well as adenine and adenosine failed to reverse the compactin inhibition of DNA synthesis (data not shown).
As indicated in Fig. 3 , at 100 AM, mevalonolactone largely reversed the compactin inhibition of DNA replication; at levels of 400 ,uM, it completely restored DNA replication. There was no significant difference between the maximal stimulatory activity of the acid and lactone forms of mevalonate. As illustrated in Fig. 3 Finally, as previously reported, the addition of cholesterol at concentrations from 1.0 to 400 MM had no significant effect on DNA replication (Fig. 3) .
Isopentenyladenine-Induced Stimulation of DNA Synthesis During the Cell Cycle. As shown in Fig. 4 Fig. 5 , nalidixic acid influenced DNA replication in a manner similar to that of compactin in that both compounds blocked dThd incorporation into DNA specifically during the S phase of the cell cycle.
As indicated in Fig. 5 , mevalonic acid fully reversed the inhibition of S-phase DNA synthesis produced by nalidixic acid treatment but had no apparent effect on DNA synthesis during any other phase of the cell cycle. Fig. 5 Isopentenyladenine and zeatin are two of a series of cytokinins first identified, respectively, in Cornyebacteriumfascians (21) and in corn (22) . These compounds stimulate cell growth in plant tissue, and although their exact mechanism of action is unknown, their potency and rapidity of action in plant systems suggest a role in cell proliferation. Peterkofsky (23) has demonstrated that isopentenyladenine present in tRNA is synthesized from mevalonate in Lactobacillus acidophilus. The presence of free isopentenyladenine in animal tissues has not been demonstrated. The synthesis of isopentenyladenine seems likely in higher animals because the compound has been identified in tRNA of both human and calf liver (24) .
As noted above, our previous studies have demonstrated that the addition of lipoprotein-bound cholesterol to cultured BHK cells, even though increasing the concentration of intracellular cholesterol, would not reverse the compactin-induced inhibition of DNA synthesis. This finding strongly suggested that the effect of mevalonate on DNA synthesis is independent of its conversion to cholesterol, but the possibility remained that a small pool of endogenous cholesterol derived from the added mevalonate might stimulate DNA synthesis. The finding that isopentenyladenine in micromolar amounts can activate S-phase DNA replication in the absence of endogenous or exogenous mevalonate, coupled with the unlikelihood that isopentenyladenine can be converted to cholesterol, supports the conclusion that mevalonate regulation of DNA synthesis is independent of its conversion to cholesterol.
A second, unexpected finding in the present study is that both mevalonic acid and isopentenyladenine will reverse the inhibition of DNA synthesis produced by nalidixic acid. Nalidixic acid inhibits DNA synthesis in eukaryotes, presumably by blocking DNA polymerase (25) . The extensive studies of Gellert and coworkers (26) (27) (28) (29) in prokaryotes have shown that this antibiotic specifically inhibits the activity of DNA gyrase, the enzyme responsible for the negative supercoiling of circular DNA. This enzyme appears to have two actions: one involves the ATP-dependent supercoiling of the DNA double helix and the other, inhibited by nalidixic acid, catalyzes the opening and closing of the DNA strand. Castora and Simpson (30) have reported evidence that DNA gyrase is present in mammalian mitochondria and that nalidixic acid will depress the synthesis of supercoiled forms of mitochondrial DNA. The exact mechanism by which nalidixic acid inhibits DNA synthesis in the nucleus, however, remains to be determined.
The present study demonstrates that levels of nalidixic acid that completely inhibit DNA replication have no effect on cholesterol synthesis and, therefore, on mevalonic acid production. It is apparent, therefore, that in contrast to that caused by compactin, the inhibition of DNA replication produced by nalidixic acid is not mediated by depriving the cell, and presumably its nucleus, of either mevalonic acid or cholesterol. It is therefore surprising that the addition of either mevalonic acid or its putative mediator, isopentenyladenine, reversed the nalidixic acid-induced inhibition of DNA replication. A theoretical explanation for this phenomenon, as suggested schematically in Fig. 6 , is that both isopentenyladenine (or a related isoprene) and nalidixic acid act at a single enzymatic site involved in DNA replication. Occupation of this site by isopentenyladenine would cause activation (and occupation by nalidixic acid would cause inhibition) of the a DNA polymerase or, conceivably, a still unidentified nuclear DNA gyrase responsible for DNA replication.
This suggestion is also supported by the finding that isopentenyladenine influences only S-phase DNA synthesis in nalidixic acid-treated cells. It is also consistent with the observation that the mevalonate concentration required to reverse the nalidixic acid inhibition of S-phase DNA synthesis is lower than that needed to reverse the compactin inhibition. In the former case, endogenous mevalonate production and presumably normal levels of intracellular mevalonate would be available to supplement that added to the culture medium. On the other hand, compactin-treated cells would have little or no intracellular mevalonate available to complement the exogenous mevalonate.
Further studies will be necessary to elucidate the exact mechanism by which isopentenyladenine (or perhaps other purine derivatives of mevalonate) may regulate DNA replication. Nonetheless, the finding that a specific mevalonate derivative can control DNA synthesis-coupled with the previous observation that the feedback control of mevalonate production is consistently and uniquely lost in malignant (7) (8) (9) (10) (11) (12) (13) (14) and in premalignant cells (7)-further supports our earlier suggestion (7) that derangements in the control of mevalonic acid production may play a role in the transformation of normal cells into cancer cells.
Note Added in Proof. After we submitted this manuscript, Habenicht et al. (31) confirmed our earlier finding (16) that mevalonate is required for DNA synthesis.
